INC Research Announces Updates to Board of Directors

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
INC Research Announces Updates to Board of Directors

RALEIGH, N.C., Oct. 31, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq: INCR ), a leading, global Phase I to IV contract research organization, today announced the appointment of Kenneth F. Meyers, Senior Vice President and Chief Human Resources Officer at Hill-Rom to the Company’s Board of Directors and the Compensation Committee of the Board and Matthew E. Monaghan, President and Chief Executive Officer at Invacare Corporation, to the Company’s Board of Directors and the Nominating and Corporate Governance Committee of the Board.  Both Mr. Meyers and Mr. Monaghan join the INC Research Board as independent directors and will be Class III directors serving a term ending at the Company’s 2017 Annual Meeting. In conjunction with these appointments, the Company also announced the resignation of Terry Woodward as a Director of the Company effective December 31, 2016. Mr. Woodward has been a member of the INC Research Board of Directors since 2010.

“We are pleased to welcome Ken and Matt to the INC Research Board,” said Alistair Macdonald, Chief Executive Officer. “Ken brings direct knowledge of the challenges associated with building a global workforce in the biopharmaceutical industry from an HR perspective.  We believe his insight in this area will be invaluable to INC as we continue to expand worldwide and focus on being the ‘CRO of Choice’ for customers, employees and other stakeholders alike.  Matt brings to the board global experience in healthcare management with specific expertise in certain medical device industries. We believe his guidance will be exceptionally valuable as we continue to develop INC’s capabilities in this important area. We are delighted to have such experienced healthcare professionals join our Board to help guide the overall direction of our Company.” Mr. Macdonald concluded, "We also want to thank Terry Woodward for his contributions to INC's board during a pivotal period in our growth and our transition from a private to public company."

Mr. Meyers brings to the INC Research Board more than 25 years of international human resources experience.  Currently Senior Vice President and Chief Human Resources Officer at Hill-Rom, a global medical technologies company, he previously held the same role at Hospira, Inc., a manufacturer and distributor of generic injectable pharmaceuticals, biosimilars and medical devices, until its acquisition by Pfizer, Inc. in 2015.  Mr. Meyers also has served in senior human resources roles for Mercer/Oliver Wyman, Starbucks Coffee International, The Gymboree Corporation, Walt Disney Imagineering and United Technologies Corporation.

Mr. Meyers currently serves on the Board of Directors for Elyssa’s Mission, a community-based non-profit organization dedicated to preventing teen suicide.  He also is a member of the Board of Directors and Chair of the Compensation Committee for The Henry P. Kendall Foundation, an organization working to create healthy and sustainable food systems in New England.  Mr. Meyers holds a Bachelor’s degree with dual majors in International Business and Human Resource Management from the Wharton School of the University of Pennsylvania and an MBA from the Harvard Business School.

Mr. Monaghan brings nearly three decades of professional experience in medical device development, operating management for private equity investors, and manufacturing. He is currently Chairman, President and Chief Executive Officer of Invacare Corporation, a medical device manufacturer for the home and long-term healthcare markets.  Prior to joining Invacare, he served as Senior Vice President, Hips and Reconstructive Research for Zimmer Holdings, Inc., a global company that designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  He also has served in operating management roles for Texas Pacific Group and Cerberus Capital Management.  He started his career at General Electric Company, including roles in aerospace and medical systems.

Mr. Monaghan is a trustee of Cleveland Clinic Avon Lake Hospital.  He holds a Bachelor’s degree in Mechanical Engineering from Cornell University, a Master’s degree in Mechanical Engineering from MIT and an MBA from INSEAD in France.

About INC Research INC Research (Nasdaq: INCR ) is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was named “Best Contract Research Organization” in December 2015 by an independent panel for Scrip Intelligence, and ranked “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey.  INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 110 countries. For more information, please visit www.incresearch.com and connect with us on LinkedIn and Twitter @inc_research .

CONTACT: Investor Relations Contact: Ronnie Speight Vice President, Investor Relations Phone: +1 (919) 745-2745 Email: Investor.Relations@incresearch.com Press/Media Contacts: Lori Dorer Senior Director, Corporate Communications Phone: +1 (513) 763-1380 Email: Corporate.Communications@incresearch.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 332

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 199

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 509

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 47

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 19

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 287

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 78

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 241

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading

Top 5 Most Recently Viewed Articles

John T Kim Expands Holdings with $9.65M in Amkor Tech Stock

Updated Category News Views 197

John T Kim Makes Significant Investment in Amkor Tech In a recent SEC filing, substantial insider trading activity was reported, showing that John T Kim, who holds a 10% stake in Amkor Technology Inc. (NASDAQ: AMKR), has acquired shares worth approximately $9.65 million. This key transaction was disclosed in a Form 4 filing, indicating Kim's commitment to the company amid...

Continue Reading
Delcath Systems: Recent Financial Gains and Future Growth Prospects

Updated Category News Views 154

Delcath Systems Secures Significant Funding Delcath Systems, Inc. (NASDAQ:DCTH) is making headlines with the successful exercise of Series E and E1 warrants, bringing in a notable $16.3 million. This funding marks a strategic move for the company, especially following a private placement that took place a few years ago. The timing of this financial boost couldn't be...

Continue Reading
Resolver's Innovative CSAM Detection Service Launch Explained

Updated Category News Views 348

Resolver Launches Pioneering Service for CSAM Detection Resolver, a leading provider of trust and safety intelligence, has introduced an innovative Unknown CSAM Detection Service. This service empowers platforms and services with the capability to identify and classify unknown child sexual abuse material (CSAM) with high precision. Identifying the Challenge in the Digital...

Continue Reading
HanesBrands Finalizes Sale of Champion Business to Authentic Brands

Updated Category News Views 151

HanesBrands Inc. (NYSE: HBI) wrapped up the sale of its global Champion business to Authentic Brands Group, shifting ownership of key intellectual property and assets associated with the brand. Transaction Impact: Simplification or Just Smoke? This deal isn't just another footnote in corporate history; it's a bold stroke by CEO Steve Bratspies who underscored that this...

Continue Reading
NVIDIA's Options Activity: Insights and Market Projections

Updated Category News Views 192

NVIDIA's Options Activity: Insights and Market Projections Financial giants have made a strong bullish move on NVIDIA. An analysis of options history for NVIDIA (NASDAQ: NVDA) revealed a significant number of unusual trades, indicating a growing interest among large-scale investors. As we dig deeper, we find that 45% of traders favor a bullish outlook, while 40% express...

Continue Reading